Medical R&D firm Celsion of Columbia, MD, announced that it has appointed Dr. Nicholas Borys to the position of vice president and chief medical officer (CMO).
Borys, who will manage Celsion's clinical development program, most recently served as CMO at Molecular Insight Pharmaceuticals. He has also held senior positions as Taiho Pharma USA, Cytogen, Anthra Pharmaceuticals, Amersham Healthcare, and Hoffmann-La Roche.
By AuntMinnie.com staff writers
September 27, 2007
Related Reading
Celsion sells subsidiary to former CEO, January 17, 2006
Celsion receives CPT code, July 24, 2003
Celsion applies for phase II trials of breast cancer ablation system, November 10, 2002
Copyright © 2007 AuntMinnie.com